The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 6 Things Endocrinologists Want Rheumatologists to Know

6 Things Endocrinologists Want Rheumatologists to Know

May 17, 2018 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

This is why Dr. Miller urges rheumatologists to get in touch with the patient’s endocrinologist or primary care physician (PCP) before starting glucocorticoids—and to let the patient know the importance of this communication and collaboration. “I’ll tell patients to give me a call, and we can devise changes to their diabetes regimen that prevent their blood sugar from going up too much,” Dr. Miller says. Some patients and doctors are good about making that call; others are not.

You Might Also Like
  • Rheumatology Coding Corner Question: New Patient Prolonged Service Without Direct Patient Contact, Part 1
  • Type 1 Diabetes Often Comes with Other Autoimmune Diseases
  • Psoriasis May Carry Atherosclerosis Risk Similar to that with Diabetes
Explore This Issue
May 2018
Also By This Author
  • A New Frailty Index Aids Lupus Assessment

The use of glucocorticoids can increase the need for daily insulin by 20–50%, Dr. Miller says. He will increase a patient’s insulin use accordingly when the patient is using glucocorticoids.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The kind of insulin used may change during treatment with glucocorticoids, says endocrinologist Elizabeth S. Halprin, MD, clinical director, Adult Diabetes, Joslin Diabetes Center, Boston. She sometimes prescribes an older insulin, called NPH, when patients use prednisone every morning.

Even with these measures, it can be hard to maintain blood sugar control, and Dr. Miller cautions patients to expect reasonable, but not perfect, blood sugar numbers when they are using steroids.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As an extra safety measure, do your best to communicate any major medication change with a patient’s diabetes care provider, Dr. Vasquez advises. “It is essential for an endocrinologist to know the specific therapy, drug type and dose that a patient with a rheumatological disease is using to tailor their diabetic treatment appropriately,” she says.

2. Push physical activity.

“Lifestyle modifications, including weight loss and exercise, are important for both diabetes and arthritis,” says rheumatologist Petros Efthimiou, MD, FACR, clinical professor of medicine, NYU Langone Health, New York. “Many times, the rheumatologist will manage the concomitant arthritis so the patient can exercise more, lose weight, and decrease cardiovascular risk factors.”

When Dr. Askanase treats a patient with both diabetes and a rheumatological disease, she emphasizes weight loss, exercise and tight diabetes control.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Of course, some patients may have limitations on how, or how often, they can move. Dr. Halprin works closely with exercise physiologists to tailor physical activity for each patient based on the individual’s joint issues. Still, everyone can benefit from some sort of movement.

“A very small increase will help, such as chair exercises, bands or a 10-minute walk a day,” Dr. Halprin says. “There’s always some movement that can be done.”

Water exercises, low-impact cardio and physical therapy also may be recommended for patients with diabetes and functional limitations from joint pain, Dr. Vasquez says.

3. Encourage education.

Physical therapist and diabetes educator Karen Kemmis, PT, DPT, CDE, FAADE, SUNY Upstate Medical University, Syracuse, New York, encourages those with a rheumatological disease and diabetes to see a diabetes educator for better education and support. A rheumatologist can suggest such a visit to patients, even if they need to follow up with their PCP or endocrinologist for more information or a referral. When a patient sees a diabetes educator, self-care behaviors, such as healthy eating, being active, taking medication and healthy coping are covered, Dr. Kemmis says. “A complete evaluation would be performed, followed by an individualized plan that would take the rheumatological disease, treatments, and effects of treatments into account,” she says.

4. Closely monitor the patient’s falls and fracture risk.

This is likely something you are already doing if a patient has RA, osteo­porosis or other rheumatologic illness. However, there’s another reason why you should assess and monitor falls and fracture risk.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: collaboration, communication, diabetes, interdisciplinary, SteroidsIssue: May 2018

You Might Also Like:
  • Rheumatology Coding Corner Question: New Patient Prolonged Service Without Direct Patient Contact, Part 1
  • Type 1 Diabetes Often Comes with Other Autoimmune Diseases
  • Psoriasis May Carry Atherosclerosis Risk Similar to that with Diabetes
  • Can Rheumatologists Prescribe Exercise as Medicine?

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)